SB 2314 Mississippi Senate · 2025 Regular Session

Uniform Controlled Substances Law; include certain hemp products on Schedule I.

This bill would have classified unapproved hemp products designed for human consumption (like edibles, vapes, or oils) as Schedule I controlled substances in Mississippi. It specifically targets hemp-derived items not approved by the U.S. Food and Drug Administration (FDA), placing them in the strictest drug category alongside substances like fentanyl. If enacted, these products would be treated as illegal drugs with no accepted medical use under state law. The bill died in committee in March 2025 and did not become law.

Issues: ✗ Healthcare

Bill status died 3 of 5 stages cleared

Introduction

Feb 2025

Committee Review

Mar 2025

Senate Passage

Feb 2025

House Passage

Governor

Introduced Feb 10, 2025 Last action Mar 12, 2025

Maddy AI version diff · 1 comparison

What changed between versions

As Introduced → Current version · 6 edits

MODERATE

This bill updates Mississippi's controlled substances law to include specific hemp-derived products in Schedule I if they are not approved by the FDA. It adds a comprehensive list of new drugs, including various synthetic opioids, hallucinogens, depressants, stimulants, and synthetic cannabinoids that were not previously explicitly listed. The bill also clarifies exemptions for industrial hemp and certain THC-containing products regulated under separate state law.

Scope change

The bill significantly expands the scope of Schedule I controlled substances by adding numerous specific chemical compounds and categories of synthetic drugs, particularly focusing on fentanyl analogs and new psychoactive substances.

SCOPE

Added extensive list of specific synthetic opioids and fentanyl analogs to Schedule I, including over 70 new chemical compounds and structural variants.

Added comprehensive list of hallucinogenic substances including synthetic cannabinoids, NBOMe compounds, and various tryptamine derivatives.

Added new categories for depressants (benzodiazepine analogs) and stimulants (synthetic cathinones) to Schedule I.

DEFINITION

Clarified that hemp-derived products designed for human ingestion or consumption are included in Schedule I unless approved by the FDA.

EXEMPTIONS

Added specific exemptions for industrial hemp products, THC-containing industrial products, and FDA-approved hemp-derived products.

REQUIREMENT

Established effective date of July 1, 2025 for the new controlled substance provisions.

Floor votes · Senate Feb 6, 2025

How they voted

51–0

Passed

Total votes 51

Feb 6, 2025

D Democratic16

16 Yea

100% Yea

R Republican35

35 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 3, 2025

Lower · Passed

Title Suff Do Pass

lower

Feb 14, 2025

Committee

Referred To Business and Commerce;Judiciary B

lower

Feb 10, 2025

Introduced

Transmitted To House

upper

Feb 6, 2025

Upper · Passed

Passed

upper

Jan 28, 2025

Upper · Passed

Title Suff Do Pass

upper

Jan 20, 2025

Committee

Referred To Judiciary, Division B

upper

1 primary · 0 co-sponsors